title: High and abnormal forms of aggression in rats with extremes in trait anxiety--involvement of the dopamine system in the nucleus accumbens.
abstract: A better neurobiological understanding of high and abnormal aggression based on adequate animal models is essential for novel therapy and prevention. Selective breeding of rats for extremes in anxiety-related behavior resulted in two behavioral phenotypes with high and abnormal forms of aggression. Rats bred for low anxiety-related behavior (LAB) consistently show highest levels of aggression and little social investigation in the resident-intruder (RI) test, compared with non-selected low-aggressive (NAB) rats. High anxiety-related (HAB) rats also show higher levels of aggression than NAB rats, but to a lesser extent than LAB rats. Accordingly, extremes in inborn anxiety in both directions are linked to an increased aggression level. Further, both LAB and HAB, but not NAB males, display abnormal aggression (attacks towards vulnerable body parts, females or narcotized males), which is particularly prominent in LABs. Also, only in LAB rats, the nucleus accumbens (NAc) was found to be strongly activated in response to the RI test as reflected by increased c-fos and zif268 mRNA expression, and higher local dopamine release compared with NAB males, without differences in local dopamine receptor binding. Consequently, local pharmacological manipulation by infusion of an anesthetic (lidocaine, 20 μg/μl) or a dopamine D2 (haloperidol, 10 ng/μl), but not D1 (SCH-23390 10 ng/μl), receptor antagonist significantly reduced high aggression in LAB rats. Thus, LAB rats are an adequate model to study high and abnormal aggression. In LAB males, this is likely to be linked to hyper-activation of the reward system, as found in psychopathic patients. Specifically, activation of the accumbal dopamine system is likely to underlie the high aggression observed in LAB rats.
authors.affiliation: Department of Behavioral and Molecular Neurobiology, Institute of Zoology, University of Regensburg, Universitaetsstrasse 31, 93053 Regensburg, Germany.
authors.forename: Daniela I
authors.initials: DI
authors.lastname: Beiderbeck
authors.forename: Stefan O
authors.initials: SO
authors.lastname: Reber
authors.forename: Andrea
authors.initials: A
authors.lastname: Havasi
authors.forename: Remco
authors.initials: R
authors.lastname: Bredewold
authors.forename: Alexa H
authors.initials: AH
authors.lastname: Veenema
authors.forename: Inga D
authors.initials: ID
authors.lastname: Neumann
mesh_terms: D000374:Aggression / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D017849:Animals, Inbred Strains; D001007:Anxiety / Q000378:metabolism / Q000503:physiopathology*; D001921:Brain / Q000502:physiology; D018492:Dopamine Antagonists / Q000494:pharmacology; D059290:Dopaminergic Neurons / Q000378:metabolism / Q000502:physiology*; D008012:Lidocaine / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D008845:Microinjections; D057054:Molecular Imaging / Q000379:methods; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D011954:Receptors, Dopamine / Q000378:metabolism
chemical_list: D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D008012:Lidocaine